Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Colorcon
Daiichi Sankyo
QuintilesIMS
UBS

Generated: September 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,888,745

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,888,745
Title:Applicator for inserting an implant
Abstract: The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6) extending from the housing (3), and a handle (15) for grasping and maneuvering the applicator (1) and the cannula (6) during insertion of an implant (2). In accordance with the invention, the handle (15) extends above at least part of the length of the cannula (6). Such a handle facilitates insertion of the cannula and/or accurate positioning of the implant.
Inventor(s): Van Der Graaf; Iris Epkjen Hobo (Deventer, NL), Tak; Maurice Petrus Wilhelmus (Hengelo, NL), Schmidt; Juergen (Herten, DE), Vertegaal; Hendricus Johannes (Hengelo, NL)
Assignee: Merck Sharp & Dohme B.V. (Haarlem, NL)
Application Number:11/795,796
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 8,888,745

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon Usa Inc NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,888,745

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100419Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050328
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077242

International Family Members for US Patent 8,888,745

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 056923   Try a Free Trial
Australia 2006207447   Try a Free Trial
Brazil PI0606826   Try a Free Trial
Canada 2593848   Try a Free Trial
China 101141994   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Boehringer Ingelheim
Argus Health
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.